1. |
Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ, 2003, 326(7379): 41-44.
|
2. |
Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ, 2015, 351: h5527.
|
3. |
Hajian-Tilaki K. The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation. Stat Methods Med Res, 2018, 27(8): 2374-2383.
|
4. |
陈世耀, 王吉耀. 诊断试验的研究与评价. 林果为, 王小钦, 陈世耀, 主编. 现代临床流行病学(第3版). 上海: 复旦大学出版社, 2014: 48-73.
|
5. |
Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med (Zagreb), 2016, 26(3): 297-307.
|
6. |
瞿振, 胡翠苹. 一种 ROC 曲线数据提取方法并用于 miRNA-122 诊断慢性病毒性肝炎的 Meta 分析. 循证医学, 2016, 16(3): 159-164.
|
7. |
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions, Version 5.1.0. The Cochrane Collaboration, 2011. Available at: http://handbook.cochrane.org/.
|
8. |
刘海宁, 吴昊, 姚灿, 等. Meta 分析中连续性数据的深度提取方法. 中国循证医学杂志, 2017, 17(1): 117-121.
|
9. |
何寒青, 陈坤. Meta 分析中的异质性检验方法. 中国卫生统计, 2006, 23(6): 486-487,490.
|
10. |
Liu HN, Liu TT, Wu H, et al. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods. Cancer Sci, 2018, 109(4): 1185-1194.
|
11. |
Chang PY, Chen CC, Chang YS, et al. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Oncotarget, 2016, 7(9): 10663-10675.
|
12. |
Zheng G, Du L, Yang X, et al. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer, 2014, 111(10): 1985-1992.
|
13. |
陈玉琢, 刘海宁, 刘韬韬. 结直肠癌患者血清 miRNA-767-3p 水平及其诊断意义. 复旦学报(医学版), 2018, 45(1): 52-56.
|
14. |
瞿振, 尹长青, 胡翠苹. 基于 EXCEL 软件的诊断性 Meta 分析中缺失数据的提取方法. 循证医学, 2017, 17(2): 116-119,124.
|